Published in Ann Surg on July 01, 2006
Rescue strategy for advanced liver malignancy with retrohepatic inferior vena cava thrombi: experience to promote surgical oncological benefit. World J Surg Oncol (2017) 1.38
One-step venous reconstruction using the donor's round ligament in right-lobe living-donor liver transplantation. Surg Today (2014) 0.87
The use of biological grafts for reconstruction of the inferior vena cava is a safe and valid alternative: results in 32 patients in a single institution. HPB (Oxford) (2013) 0.83
Repeat hepatectomy with inferior vena cava re-resection for colorectal liver metastases: case report and review of the literature. Surg Today (2014) 0.83
Repeated hepatic resection combined with inferior vena cava replacement: Case report and review of literature. Int J Surg Case Rep (2014) 0.83
Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford) (2011) 0.81
Excellent outcome in 238 consecutive living donor liver transplantations using the right liver graft in a large volume single center. World J Surg (2013) 0.80
Usefulness of artificial vascular graft for venous reconstruction in liver surgery. World J Surg Oncol (2014) 0.79
Combined hepatic resection with the inferior vena cava and diaphragm and reconstruction using an equine pericardial patch: report of a case. Surg Today (2011) 0.79
Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass. Surg Today (2013) 0.79
Aggressive liver resection including major-vessel resection for colorectal liver metastases. World J Hepatol (2009) 0.78
Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database. HPB (Oxford) (2015) 0.78
Ex-situ liver surgery without veno-venous bypass. World J Gastroenterol (2012) 0.78
Multiorgan resection with inferior vena cava reconstruction for hepatic alveolar echinococcosis: A case report and literature review. Medicine (Baltimore) (2016) 0.75
Hepatic colorectal metastases involving infra-hepatic inferior vena cava in high risk patients for extended resection: an alternative method for achieving radical resection in patient with borderline liver remnant. Indian J Surg (2012) 0.75
Retrohepatic inferior vena cava reconstruction with saphenous vein patch in advanced stage cholangiocarcinoma. Ulus Cerrahi Derg (2014) 0.75
Retrocaval liver lifting maneuver and modifications of total hepatic vascular exclusion for liver tumor resection. World J Hepatol (2016) 0.75
Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford) (2008) 0.75
Hepatobiliary resection with concomitant resection of the inferior vena cava for advanced intrahepatic cholangiocarcinoma: report of a case. Surg Today (2012) 0.75
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet (1998) 4.16
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg (1996) 2.35
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16
Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg Gynecol Obstet (1978) 2.13
Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. Br J Surg (1995) 1.88
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg (2002) 1.78
Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery (1984) 1.76
An improved technic for vascular isolation of the liver: experimental study and case reports. Ann Surg (1966) 1.74
Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg (2000) 1.66
Hepatocellular carcinoma: current surgical management. Gastroenterology (2004) 1.66
Resection of the inferior vena cava for neoplasms with or without prosthetic replacement: a 14-patient series. Ann Surg (2001) 1.58
Extended right hepatic lobectomy: combined resection of inferior vena cava and its reconstruction by EPTFE graft (Gore-Tex). Case report. Acta Chir Scand (1988) 1.36
Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol (2000) 1.36
The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg (1999) 1.34
Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin (2001) 1.32
Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg (2004) 1.28
Resection of the suprarenal inferior vena cava. The role of prosthetic replacement. Arch Surg (1995) 1.24
Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann Surg (1999) 1.22
Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg (1998) 1.21
Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion. Br J Surg (1985) 1.20
Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg (1996) 1.18
In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg (2005) 1.17
Total vascular exclusion of the liver during hepatic surgery. Selective use, extensive use, or abuse? Arch Surg (1997) 1.16
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Significance of hepatic resection combined with inferior vena cava resection and its reconstruction with expanded polytetrafluoroethylene for treatment of liver tumors. J Am Coll Surg (2003) 1.10
Resection of the inferior vena cava for adjacent malignant diseases. Surg Gynecol Obstet (1973) 1.10
Radiofrequency ablation of hepatic metastases. Semin Oncol (2002) 1.06
Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy? Arch Surg (2003) 1.04
A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1994) 1.04
Liver resection combined with excision of vena cava. J Am Coll Surg (2000) 1.02
Leiomyosarcoma of the retrohepatic portion of the inferior vena cava: clinical presentation and surgical management in five patients. J Am Coll Surg (2005) 1.02
A hepatoblastoma originating in the caudate lobe radically resected with the inferior vena cava. Surgery (1991) 0.97
Combined hepatic and vena caval resection with autogenous caval graft replacement. Arch Surg (1991) 0.94
Right trisegmentectomy with a synthetic vena cava graft. Arch Surg (1988) 0.93
The anterior approach: the right way for right massive hepatectomy. J Am Coll Surg (2001) 0.93
Morbidity and mortality associated with large-bore percutaneous venovenous bypass cannulation for 312 orthotopic liver transplantations. Liver Transpl (2001) 0.91
Reconstruction of the hepatic vein to the prosthetic inferior vena cava in right extended hemihepatectomy with ex situ procedure. Surgery (1994) 0.89
Use of a pericardial xenograft patch in repair of resected retrohepatic vena cava. Can J Surg (1994) 0.89
In situ pedicle resection in left trisegmentectomy of the liver combined with reconstruction of the right hepatic vein to an inferior vena caval segment transpositioned from the infrahepatic portion. J Am Coll Surg (2001) 0.85
Combined resection of the inferior vena cava and extended right hepatectomy for leiomyosarcoma of the retrohepatic cava. Br J Surg (1994) 0.83
Intracaval endovascular ultrasonography for preoperative assessment of retrohepatic inferior vena cava infiltration by malignant hepatic tumors. Hepatology (1996) 0.83
Ex vivo right trisegmentectomy with reconstruction of inferior vena cava and "flop" reimplantation. J Am Coll Surg (2002) 0.82
Retrohepatic vena cava reconstruction with polytetrafluoroethylene graft. J Vasc Surg (1990) 0.81
Patency in canine inferior vena cava grafting: effects of graft material, size, and endothelial seeding. J Vasc Surg (1984) 0.81
Extended hepatectomy with ePTFE graft vena caval replacement and hepatic vein reconstruction: a case report. Hepatogastroenterology (1999) 0.80
Retrohepatic vena cava replacement of hepatic malignancies without using total hepatic vascular exclusion or extracorporeal bypass. Hepatogastroenterology (2001) 0.80
Aggressive surgical management of fibrolamellar hepatocellular carcinoma in puberty. Eur J Surg Oncol (1997) 0.79
Extension incision for renal carcinoma including invaded vena cava and right lobe of liver. Urology (1992) 0.78
A percutaneous technique for venovenous bypass in orthotopic cadaver liver transplantation and comparison with the open technique. Liver Transpl Surg (1996) 0.78
Combined right hepatic and retrohepatic caval resection with reconstruction using a polytetrafluoroethylene graft for primary leiomyosarcoma of the liver: report of case. Surg Today (1999) 0.78
Intracaval endovascular ultrasonography for large adrenal and retroperitoneal tumors. Surgery (2003) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol (2006) 2.49
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol (2008) 2.44
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol (2009) 2.26
Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology (2011) 2.25
Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation (2002) 2.19
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol (2011) 1.99
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg (2008) 1.88
Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg (2011) 1.83
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg (2002) 1.78
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol (2008) 1.70
Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol (2013) 1.68
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. J Hepatol (2010) 1.60
Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg (2008) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology (2008) 1.47
Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation. World J Surg (2014) 1.42
Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transplant (2005) 1.41
Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol (2004) 1.41
Split liver transplantation using extended right grafts: the natural history of segment 4 and its impact on early postoperative outcomes. Liver Transpl (2012) 1.40
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl (2007) 1.31
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology (2008) 1.30
Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Liver Transpl (2008) 1.27
Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience. HPB (Oxford) (2013) 1.27
Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis (2011) 1.26
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol (2007) 1.23
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg (2006) 1.20
In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg (2005) 1.17
Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl (2009) 1.15
New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clin Chem Lab Med (2007) 1.15
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Cancer Chemother Pharmacol (2010) 1.14
KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors. Clin Cancer Res (2008) 1.13
Colon cancer prognosis prediction by gene expression profiling. Oncogene (2005) 1.13
Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg (2011) 1.12
Length analysis of polymerase chain reaction products: a sensitive and reliable technique for the detection of mutations in KIT exon 11 in gastrointestinal stromal tumors. Diagn Mol Pathol (2002) 1.11
Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients. HPB (Oxford) (2013) 1.10
Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg (2006) 1.10
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology (2011) 1.08
Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg (2002) 1.05
Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest (2006) 1.02
Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation (2003) 1.02
Therapeutic strategies in symptomatic portal biliopathy. Ann Surg (2007) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer. Cancer (2009) 1.01
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas. Oncology (2007) 1.01
Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver Transpl (2003) 1.00
First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J Antimicrob Chemother (2005) 1.00
Pure laparoscopic left lateral sectionectomy in living donors: from innovation to development in France. Ann Surg (2015) 0.99
A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl (2008) 0.99